SI2440253T1 - Alkil fosfolipidne spojine za zdravljenje raka in slikanje in detekcijo rakavih izvornih celic - Google Patents
Alkil fosfolipidne spojine za zdravljenje raka in slikanje in detekcijo rakavih izvornih celicInfo
- Publication number
- SI2440253T1 SI2440253T1 SI201032012T SI201032012T SI2440253T1 SI 2440253 T1 SI2440253 T1 SI 2440253T1 SI 201032012 T SI201032012 T SI 201032012T SI 201032012 T SI201032012 T SI 201032012T SI 2440253 T1 SI2440253 T1 SI 2440253T1
- Authority
- SI
- Slovenia
- Prior art keywords
- imaging
- detection
- stem cells
- cancer
- phospholipid compounds
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/0489—Phosphates or phosphonates, e.g. bone-seeking phosphonates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
- A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/0404—Lipids, e.g. triglycerides; Polycationic carriers
- A61K51/0408—Phospholipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
- A61N5/1001—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy using radiation sources introduced into or applied onto the body; brachytherapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
- A61N5/1001—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy using radiation sources introduced into or applied onto the body; brachytherapy
- A61N2005/1019—Sources therefor
- A61N2005/1021—Radioactive fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/02—Radiation therapy using microwaves
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Physics & Mathematics (AREA)
- Optics & Photonics (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Urology & Nephrology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Dermatology (AREA)
- Oncology (AREA)
- Pulmonology (AREA)
- Pathology (AREA)
- Radiology & Medical Imaging (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US18660009P | 2009-06-12 | 2009-06-12 | |
PCT/US2010/038294 WO2010144788A2 (en) | 2009-06-12 | 2010-06-11 | Ether and alkyl phospholipid compounds for treating cancer and imaging and detection of cancer stem cells |
EP10786904.2A EP2440253B1 (en) | 2009-06-12 | 2010-06-11 | Alkyl phospholipid compounds for treating cancer and imaging and detection of cancer stem cells |
Publications (1)
Publication Number | Publication Date |
---|---|
SI2440253T1 true SI2440253T1 (sl) | 2020-09-30 |
Family
ID=43306617
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SI201032012T SI2440253T1 (sl) | 2009-06-12 | 2010-06-11 | Alkil fosfolipidne spojine za zdravljenje raka in slikanje in detekcijo rakavih izvornih celic |
SI201032132T SI3708192T1 (sl) | 2009-06-12 | 2010-06-11 | Eter fosfolipidne spojine za zdravljenje raka in slikanje in detekcijo rakavih izvornih celic |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SI201032132T SI3708192T1 (sl) | 2009-06-12 | 2010-06-11 | Eter fosfolipidne spojine za zdravljenje raka in slikanje in detekcijo rakavih izvornih celic |
Country Status (8)
Country | Link |
---|---|
US (3) | US20100316567A1 (sl) |
EP (3) | EP2440253B1 (sl) |
JP (2) | JP6092624B2 (sl) |
DK (2) | DK2440253T3 (sl) |
ES (2) | ES2799411T3 (sl) |
RU (1) | RU2012100765A (sl) |
SI (2) | SI2440253T1 (sl) |
WO (1) | WO2010144788A2 (sl) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2440257T3 (es) | 2004-03-02 | 2014-01-28 | Cellectar, Inc. | Análogo fosfolipídico para el diagnóstico in vivo de cánceres |
US8540968B2 (en) | 2004-03-02 | 2013-09-24 | Cellectar, Inc. | Phospholipid ether analogs as agents for detecting and locating cancer, and methods thereof |
WO2010132428A1 (en) | 2009-05-11 | 2010-11-18 | Cellectar, Inc. | Fluorescent phospholipid ether compounds, compositions, and methods of use |
US8871181B2 (en) | 2009-05-11 | 2014-10-28 | Cellectar, Inc. | Fluorescent phospholipid ether compounds, compositions, and methods of use |
JP6092624B2 (ja) | 2009-06-12 | 2017-03-08 | セレクター,インコーポレイティド | 癌の治療並びに癌幹細胞の造影および検出のためのエーテルおよびアルキルリン脂質化合物 |
US20110064660A1 (en) * | 2009-09-11 | 2011-03-17 | Pinchuk Anatoly | Deuterated alkyl phospholipid compounds, compositions, and methods of use |
RU2012114146A (ru) * | 2009-09-11 | 2013-10-20 | Селлектар, Инк. | Нерадиоактивные фосфолипидные соединения, композиции и способы их применения |
WO2016073737A1 (en) | 2014-11-05 | 2016-05-12 | The Regents Of The University Of California | Methods of selecting and isolating cancer stem cells |
CA2968145C (en) | 2014-11-17 | 2023-06-27 | Cellectar Biosciences, Inc. | Phospholipid ether analogs as cancer-targeting drug vehicles |
CN108430520B (zh) * | 2015-11-06 | 2021-08-13 | 威斯康星校友研究基金会 | 长效钆基肿瘤靶向成像与治疗剂 |
JP2017135134A (ja) | 2016-01-25 | 2017-08-03 | パナソニックIpマネジメント株式会社 | 発光装置 |
US11147823B2 (en) * | 2016-07-13 | 2021-10-19 | Wisconsin Alumni Research Foundation | Phospholipid ether analogs for imaging and targeted treatment of pediatric solid tumors |
US11633506B2 (en) | 2016-07-18 | 2023-04-25 | Wisconsin Alumni Research Foundation | Using targeted radiotherapy (TRT) to drive anti-tumor immune response to immunotherapies |
AU2017300361A1 (en) * | 2016-07-18 | 2019-02-07 | Wisconsin Alumni Research Foundation | Radiohalogenated agents for In Situ Immune Modulated Cancer Vaccination |
KR102332958B1 (ko) * | 2016-07-25 | 2021-11-29 | 위스콘신 얼럼나이 리서어치 화운데이션 | 암 영상화 및 치료를 위한 방사성 인지질 금속 킬레이트 |
CN109789207B (zh) * | 2016-07-25 | 2022-11-18 | 威斯康星校友研究基金会 | 用于原位免疫调节的癌症疫苗接种的靶向放射治疗螯合物 |
KR20200088374A (ko) * | 2017-11-10 | 2020-07-22 | 위스콘신 얼럼나이 리서어치 화운데이션 | 면역요법에 대한 항-종양 면역 반응을 유도하기 위해 표적화된 방사선요법(trt)을 이용하는 방법 |
JP2021521174A (ja) * | 2018-04-10 | 2021-08-26 | セレクター・バイオサイエンシズ・インコーポレイテッド | 癌治療のためのエーテル型リン脂質類似体の分割投与 |
JP2022551495A (ja) * | 2019-10-10 | 2022-12-09 | セレクター・バイオサイエンシズ・インコーポレイテッド | リン脂質-フラバグリン抱合体及び標的化されたがん治療のためのリン脂質-フラバグリン抱合体の使用方法 |
IL291980A (en) * | 2019-10-10 | 2022-06-01 | Cellectar Biosciences Inc | Fractionated Dose of a Phospholipid Ether Analogue for Cancer Treatment |
Family Cites Families (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4925649A (en) * | 1987-06-12 | 1990-05-15 | The University Of Michigan | Radioiodinated diacylglycerol analogues and methods of use |
US4965391A (en) * | 1987-10-23 | 1990-10-23 | The University Of Michigan | Radioiodinated phospholipid ether analogues |
US5347030A (en) * | 1987-10-23 | 1994-09-13 | The Board Of Regents Of The University Of Michigan | Radioiodinated phospholipid ether analogues and methods of using same |
US5087721A (en) * | 1987-10-23 | 1992-02-11 | The University Of Michigan | Radioiodinated phosphate esters |
US5274113A (en) * | 1991-11-01 | 1993-12-28 | Molecular Probes, Inc. | Long wavelength chemically reactive dipyrrometheneboron difluoride dyes and conjugates |
US5369097A (en) * | 1991-04-25 | 1994-11-29 | The University Of British Columbia | Phosphonates as anti-cancer agents |
US5783170A (en) * | 1991-11-27 | 1998-07-21 | Diatide, Inc. | Peptide-metal chelate conjugates |
US5626654A (en) * | 1995-12-05 | 1997-05-06 | Xerox Corporation | Ink compositions containing liposomes |
US6255519B1 (en) * | 1996-12-04 | 2001-07-03 | Regents Of The University Of Michigan | Radioiodinated phospholipid ether analogs and methods of using the same |
CA2276284C (en) | 1996-12-04 | 2006-10-10 | The Regents Of The University Of Michigan | Radioiodinated phospholipid ether analogs and methods of using the same |
US6503478B2 (en) * | 1999-01-13 | 2003-01-07 | Lightouch Medical, Inc. | Chemically specific imaging of tissue |
PT1200117E (pt) | 1999-06-24 | 2008-11-26 | Univ British Columbia | Tratamento à base de variantes da lipoproteína lipase |
JP2003088366A (ja) | 2001-09-07 | 2003-03-25 | Res Dev Found | 膵臓島細胞におけるインシュリン発現を刺激する新しいホメオボックス因子 |
DE60331827D1 (de) | 2002-05-29 | 2010-05-06 | Immunomedics Inc | Zusammensetzungen für die radioimmuntherapie von gehirn-tumoren |
US7220539B1 (en) * | 2002-06-12 | 2007-05-22 | The Salk Institute For Biological Studies | Protein kinase B/Akt modulators and methods for the use thereof |
CA2539107A1 (en) | 2003-09-19 | 2005-03-31 | Arcturus Bioscience, Inc. | Predicting breast cancer treatment outcome |
US7829742B2 (en) | 2003-12-22 | 2010-11-09 | Johns Hopkins University | Boronic acid aryl analogs |
US8540968B2 (en) | 2004-03-02 | 2013-09-24 | Cellectar, Inc. | Phospholipid ether analogs as agents for detecting and locating cancer, and methods thereof |
ES2440257T3 (es) | 2004-03-02 | 2014-01-28 | Cellectar, Inc. | Análogo fosfolipídico para el diagnóstico in vivo de cánceres |
US7632644B2 (en) * | 2004-03-02 | 2009-12-15 | Cellectar, Inc. | Imaging and selective retention of phospholipid ether analogs |
MXPA06011242A (es) * | 2004-03-29 | 2007-01-16 | Univ Arizona | Glicopeptidos anfipaticos. |
MX2007000207A (es) | 2004-07-08 | 2007-03-30 | Cellectar Llc | Colonoscopia virtual con analogos de eter de fosfolipido radiomarcados. |
US20060115426A1 (en) * | 2004-08-11 | 2006-06-01 | Weichert Jamey P | Methods of detecting breast cancer, brain cancer, and pancreatic cancer |
US7041859B1 (en) * | 2004-09-09 | 2006-05-09 | University Of Tennessee Research Foundation | Method for halogenating or radiohalogenating a chemical compound |
JP2008545614A (ja) | 2004-12-20 | 2008-12-18 | セレクター、リミテッド ライアビリティ カンパニー | 癌の検出および治療のためのリン脂質エーテル類似体 |
AU2007355882A1 (en) * | 2006-08-15 | 2009-01-08 | Cellectar, Inc. | Near infrared-fluorescence using phospholipid ether analog dyes in endoscopic applications |
US7893286B2 (en) * | 2007-06-01 | 2011-02-22 | Cellectar, Inc. | Method for the synthesis of phospholipid ethers |
US8022235B2 (en) | 2007-06-01 | 2011-09-20 | Cellectar, Inc. | Compositions of phospholipid ether boronic acids and esters and methods for their synthesis and use |
WO2009148623A2 (en) * | 2008-06-05 | 2009-12-10 | Stc.Unm | Methods and related compositions for the treatment of cancer |
GB0819280D0 (en) * | 2008-10-21 | 2008-11-26 | Gen Electric | Imgaing and radiotherapy methods |
WO2010132428A1 (en) * | 2009-05-11 | 2010-11-18 | Cellectar, Inc. | Fluorescent phospholipid ether compounds, compositions, and methods of use |
JP6092624B2 (ja) | 2009-06-12 | 2017-03-08 | セレクター,インコーポレイティド | 癌の治療並びに癌幹細胞の造影および検出のためのエーテルおよびアルキルリン脂質化合物 |
RU2012114146A (ru) * | 2009-09-11 | 2013-10-20 | Селлектар, Инк. | Нерадиоактивные фосфолипидные соединения, композиции и способы их применения |
US20110064660A1 (en) * | 2009-09-11 | 2011-03-17 | Pinchuk Anatoly | Deuterated alkyl phospholipid compounds, compositions, and methods of use |
-
2010
- 2010-06-11 JP JP2012515178A patent/JP6092624B2/ja active Active
- 2010-06-11 WO PCT/US2010/038294 patent/WO2010144788A2/en active Application Filing
- 2010-06-11 EP EP10786904.2A patent/EP2440253B1/en active Active
- 2010-06-11 DK DK10786904.2T patent/DK2440253T3/da active
- 2010-06-11 SI SI201032012T patent/SI2440253T1/sl unknown
- 2010-06-11 ES ES10786904T patent/ES2799411T3/es active Active
- 2010-06-11 US US12/813,992 patent/US20100316567A1/en not_active Abandoned
- 2010-06-11 DK DK20172745.0T patent/DK3708192T3/da active
- 2010-06-11 EP EP23184743.5A patent/EP4248999A3/en active Pending
- 2010-06-11 SI SI201032132T patent/SI3708192T1/sl unknown
- 2010-06-11 EP EP20172745.0A patent/EP3708192B1/en active Active
- 2010-06-11 RU RU2012100765/15A patent/RU2012100765A/ru unknown
- 2010-06-11 ES ES20172745T patent/ES2959862T3/es active Active
-
2013
- 2013-05-06 US US13/887,981 patent/US9339564B2/en active Active
-
2015
- 2015-09-14 JP JP2015181052A patent/JP2016011303A/ja active Pending
-
2016
- 2016-04-15 US US15/099,977 patent/US10004818B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
US20130343991A1 (en) | 2013-12-26 |
RU2012100765A (ru) | 2013-07-20 |
WO2010144788A3 (en) | 2014-03-20 |
EP2440253B1 (en) | 2020-05-13 |
EP2440253A2 (en) | 2012-04-18 |
SI3708192T1 (sl) | 2023-12-29 |
EP4248999A3 (en) | 2023-11-15 |
US9339564B2 (en) | 2016-05-17 |
EP2440253A4 (en) | 2016-01-13 |
US10004818B2 (en) | 2018-06-26 |
DK3708192T3 (da) | 2023-11-06 |
US20100316567A1 (en) | 2010-12-16 |
US20160228588A1 (en) | 2016-08-11 |
JP6092624B2 (ja) | 2017-03-08 |
EP3708192B1 (en) | 2023-08-02 |
JP2016011303A (ja) | 2016-01-21 |
DK2440253T3 (da) | 2020-07-20 |
WO2010144788A2 (en) | 2010-12-16 |
EP4248999A2 (en) | 2023-09-27 |
ES2799411T3 (es) | 2020-12-17 |
ES2959862T3 (es) | 2024-02-28 |
EP3708192A1 (en) | 2020-09-16 |
JP2012530063A (ja) | 2012-11-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SI2440253T1 (sl) | Alkil fosfolipidne spojine za zdravljenje raka in slikanje in detekcijo rakavih izvornih celic | |
IL258794B (en) | Methods and preparations for the diagnosis and treatment of cancer | |
EP2542081A4 (en) | COMPOSITIONS FOR CANCER TREATMENT | |
HK1162916A1 (en) | Methods of treatment for solid tumors | |
PL3050974T3 (pl) | Sposób detekcji narażonych na wilgoć pasków testowych do moczu | |
EP2776013A4 (en) | METHODS AND COMPOSITIONS FOR INDUCED X-RAY RELEASE OF PH-SENSITIVE LIPOSOMES | |
EP2438197A4 (en) | METHOD OF CANCER DETECTION | |
EP2675485A4 (en) | ANTI-MUCIN ANTIBODY FOR THE EARLY RECOGNITION AND TREATMENT OF PANCREATIC CANCER | |
IL214255A0 (en) | Methods and compositions for diagnosis and treatment of cancer | |
EP2643001A4 (en) | METHOD OF TREATING CANCER | |
PT2207037T (pt) | Método para a deteção de cancro | |
EP2742123A4 (en) | ISOLATION AND DETECTION OF CANCER CELLS | |
EP2428584A4 (en) | COLORECTAL TUMOR DETECTION METHOD | |
IL215949A0 (en) | Compositions and methods for determining directionality of radiation | |
EP2608671A4 (en) | COMPOUNDS USED IN THE TREATMENT OF CANCER | |
GB2467838B (en) | Means for distribution of fish | |
IL218230A0 (en) | Method of treating cancer | |
EP2471544A4 (en) | AGENT TO REDUCE THE RISK OF DEVELOPING CANCER | |
EP2643482A4 (en) | EARLY DETECTION OF PANCREATIC CANCER | |
EP2121042A4 (en) | COMPOUNDS AND METHOD FOR THE DETECTION OF CELLS | |
ZA201202379B (en) | Antagonists of dsgs2 for treatment of cancer | |
GB0906424D0 (en) | Use of compounds for differentiation of cells | |
EP2576610A4 (en) | BIOMARKERS FOR THE DIAGNOSIS AND TREATMENT OF DARM CANCER | |
EP2559380A4 (en) | SENSOR AND METHOD FOR REMOVAL OF INTERFERING SUBSTANCE | |
TWM373044U (en) | Anti-rotating adaptor for shielded structure Shielded structure of anti-rotating adaptor |